Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Life Healthcare Group ( (HK:0928) ).
King International Investment Limited has updated its board composition effective 24 April 2026, confirming a slate of five executive directors and three independent non-executive directors, with co-chairmen roles held by Leng Yueyingtan and Wang Jun. The company also detailed new memberships and chairmanships across its audit, nomination, remuneration and fund management committees, signaling a refreshed governance framework aimed at strengthening oversight and aligning board responsibilities with the group’s strategic and operational needs.
The changes assign key committee leadership roles to directors including Wang Mengyao on the audit committee, Li Qian on both the nomination and remuneration committees and Liu Zhong on the fund management committee, while other directors serve as members to ensure broader participation in governance. For shareholders and other stakeholders, the clarified division of duties across committees may enhance transparency, risk management and decision-making processes, potentially supporting the firm’s compliance posture and long-term corporate governance standards.
More about Life Healthcare Group
King International Investment Limited is an investment company incorporated in the Cayman Islands and listed in Hong Kong under stock code 928. The firm operates with a board structure that includes executive and independent non-executive directors and maintains specialized board committees overseeing audit, nomination, remuneration and fund management functions.
Average Trading Volume: 3,497,590
Technical Sentiment Signal: Sell
Current Market Cap: HK$148M
For an in-depth examination of 0928 stock, go to TipRanks’ Overview page.